Insider Transactions in Q3 2021 at Tandem Diabetes Care Inc (TNDM)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 06
2021
|
John F Sheridan PRESIDENT & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,323
+15.4%
|
$63,876
$12.97 P/Share
|
|
Aug 03
2021
|
Peyton R Howell Director |
BUY
Exercise of conversion of derivative security
|
Direct |
948
+50.0%
|
-
|
|
Aug 02
2021
|
Rebecca B Robertson Director |
SELL
Open market or private sale
|
Direct |
1,500
-79.28%
|
$160,500
$107.51 P/Share
|
|
Jul 30
2021
|
Dick Allen Director |
SELL
Open market or private sale
|
Indirect |
2,526
-33.56%
|
$270,282
$107.0 P/Share
|
|
Jul 29
2021
|
Christopher J Twomey Director |
SELL
Open market or private sale
|
Indirect |
8,000
-22.81%
|
$840,000
$105.0 P/Share
|
|
Jul 29
2021
|
Christopher J Twomey Director |
SELL
Bona fide gift
|
Indirect |
2,500
-16.63%
|
$260,000
$104.89 P/Share
|
|
Jul 27
2021
|
James Leal Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
1,666
-31.66%
|
$169,932
$102.25 P/Share
|
|
Jul 27
2021
|
James Leal Chief Manufacturing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,666
+24.05%
|
$84,966
$51.5 P/Share
|